The effect of somatostatin, ulinastatin and salvia miltiorrhiza on severe acute pancreatitis treatment

American Journal of the Medical Sciences

Volumn 346, Issue 5, 2013, Pages 371-376

  Wang, Guiliang ^a   Wen, Jianbo ^a   Wilbur, Rhonda R ^b   Wen, Ping ^a   Zhou, Shu Feng ^b   Xiao, Xianzhong ^c  

^a Department of Digestive Internal Medicine   (China)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Central South University   (China)

Author keywords

Salvia miltiorrhiza; Severe acute pancreatitis; Somatostatin; Ulinastatin

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; SALVIA MILTIORRHIZA EXTRACT; SOMATOSTATIN; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II SCORE; ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEVERE ACUTE PANCREATITIS;

EID: 84887223611     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31827aa2bc     Document Type: Article

References (25)

1. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001;22:274-8.
2. Bosscha K, Hulstaert PF, Hennipman A, et al. Fulminant acute pancreatitis and infected necrosis: results of open management of the abdomen and "planned" reoperations. J Am Coll Surg 1998;187:255-62.
3. Malmstrøm ML, Hansen MB, Andersen AM, et al. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas 2012;41:271-7.
4. Kylänpää ML, Repo H, Puolakkainen PA. Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol 2010; 16:2867-72.
5. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128:586-90.
6. Balthazar EJ. Pancreatitis associated with pancreatic carcinoma. Preoperative diagnosis: role of CT imaging in detection and evaluation. Pancreatology 2005;5:330-44.
7. Kiriyama S, Gabata T, Takada TJ, et al. New diagnostic criteria of acute pancreatitis. Hepatobiliary Pancreat Sci 2010;17:24-36.
8. Mayerle J, Dummer A, Sendler M, et al. Differential roles of inflammatory cells in pancreatitis. J Gastroenterol Hepatol 2012;27(suppl 2):47-51.
9. De Waele JJ, Hoste E, Blot SI, et al. Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005;9:R452-7.
10. Mofidi R, Duff MD, Wigmore SJ, et al. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 2006;93:738-44.
11. Al-Bahrani AZ, Abid GH, Holt A, et al. Clinical relevance of intraabdominal hypertension in patients with severe acute pancreatitis. Pancreas 2008;36:39-43.
12. Denham W, Yang J, Fink G, et al. Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology 1997;113:1741-6.
13. Grewal HP, Mohey el Din A, Gaber L, et al. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti- TNF-alpha polyclonal antibody. Am J Surg 1994;167:214-8.
14. Hughes CB, el-Din AB, Kotb M, et al. Calcium channel blockade inhibits release of TNF alpha and improves survival in a rat model of acute pancreatitis. Pancreas 1996;13:22-8.
15. Chen CC, Wang SS, Lee FY, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999;94:213-8.
16. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003;55:241-69.
17. Li J, Wang R, Tang C. Somatostatin and octreotide on the treatment of acute pancreatitis-basic and clinical studies for three decades. Curr Pharm Des 2011;17:1594-601.
18. Xia Q, Yuan L, Yang XN, et al. Comparison of integrated Chinese and Western medicine with and without somatostatin supplement in the treatment of severe acute pancreatitis. World J Gastroenterol 2005;11:1073-6.
19. Andoh A, Hata K, Shimada M, et al. Inhibitory effects of somatostatin on tumor necrosis factor-alpha-induced interleukin-6 secretion in human pancreatic periacinar myofibroblasts. Int J Mol Med 2002;10:89-93.
20. Chen S, Shi H, Zou X, et al. Role of ulinastatin in preventing postendoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp? Pancreas 2010;39:1231-7.
21. Ueki T, Otani K, Kawamoto K, et al. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol 2007;42:161-7.
22. Ma T, Kang C, Shao H, et al. Protective effects of ulinastatin on proliferation and cytokine release of splenocytes from rats with severe acute pancreatitis. Eur Surg Res 2006;38:445-50.
23. Zhang ZF, Yang N, Zhao G, et al. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis. Chin Med J (Engl) 2010;23:2600-6.
24. Ling Z, Xiping Z, Fengmei Q, et al. Protective effects of Salvia miltiorrhiza on multiple organs of rats with obstructive jaundice. Mediators Inflamm 2009;2009:602935.
25. Li M, Zhang L, Cai RL, et al. Lipid-soluble extracts from Salvia miltiorrhiza inhibit production of LPS-induced inflammatory mediators via NF-kB modulation in RAW 264.7 cells and perform antiinflammatory effects in vivo. Phytother Res 2012;26: 1195-204.